At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06887 SUNSHINE PHARMA
Closed 10-27 16:08:21
41.000
-0.200
-0.49%
High41.500
Low40.240
Vol157.60K
Open41.200
D1 Closing41.200
Amplitude3.06%
Mkt Cap23.53B
Tradable Cap13.08B
Total Shares574.00M
T/O6.43M
T/O Rate0.05%
Tradable Shares319.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Hong Kong Regulators Issue Joint Statement on Audit Opinions; Nasdaq Slides 1.25%
Sunshine Lake Pharma Co Ltd is a China-based company principally engaged in research and development, production and commercialization of pharmaceutical products. The Company focuses on innovative drugs and is also involved in modified new drugs, generic drugs and biosimilars. The Company’s anti-infective products include Kewei (oseltamivir phosphate), for the treatment of influenza (in particular, Type A and Type B influenza viruses), Dongweien (emitasvir phosphate), for the treatment of hepatitis C, and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin and Moxifloxacin Hydrochloride. The Company’s commercialized chronic disease treatment drugs primarily focus on the treatment of diabetes, hyperuricemia, hypertension and stomach acid related disease, including insulin products and generic drugs. The Company also focuses on therapeutic area of oncology.